A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Aelis Farma, a France-based drug developer spun out of Inserm, has listed on Euronext Paris following a €25m ($28.1m) initial public offering. Aelis Farma’s shareholders include Inserm’s tech transfer office, Inserm Transfert Initiative, which had helped the spinout raise a total of $14m prior to the flotation.
Dive Technologies, a US-based subsea robotics developer that is collaborating with Virginia Tech, has agreed to an acquisition by defence technology producer Anduril Industries for an undisclosed amount. Dive Technologies had obtained…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
